220 related items for PubMed ID: 23619602
1. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
[Abstract] [Full Text] [Related]
2. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012 Oct; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
3. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
4. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A, Hari P, Srivastava RN.
Pediatr Nephrol; 1999 Nov; 13(9):824-7. PubMed ID: 10603129
[Abstract] [Full Text] [Related]
5. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
6. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[Abstract] [Full Text] [Related]
7. Behavioural abnormalities in children with nephrotic syndrome.
Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F.
Nephrol Dial Transplant; 2010 Aug; 25(8):2537-41. PubMed ID: 20200003
[Abstract] [Full Text] [Related]
8. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K, Parikh A, Webb H, Hothi D.
Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
[Abstract] [Full Text] [Related]
9. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
10. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF, Brodeh J.
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[Abstract] [Full Text] [Related]
11. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
12. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Raman V, Krishnamurthy S, Harichandrakumar KT.
Pediatr Nephrol; 2016 Apr 23; 31(4):595-604. PubMed ID: 26759000
[Abstract] [Full Text] [Related]
13. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
Abeyagunawardena AS, Trompeter RS.
Arch Dis Child; 2008 Mar 23; 93(3):226-8. PubMed ID: 17573408
[Abstract] [Full Text] [Related]
14. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
Mymensingh Med J; 2014 Apr 23; 23(2):261-7. PubMed ID: 24858152
[Abstract] [Full Text] [Related]
15. Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome.
Nakanishi K, Iijima K, Ishikura K, Hataya H, Nakazato H, Sasaki S, Honda M, Yoshikawa N, Japanese Study Group of Renal Disease in Children.
Clin J Am Soc Nephrol; 2013 May 23; 8(5):756-62. PubMed ID: 23371961
[Abstract] [Full Text] [Related]
16. Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome.
Esezobor CI, Ladapo TA, Lesi FE.
Niger J Clin Pract; 2016 May 23; 19(2):254-8. PubMed ID: 26856291
[Abstract] [Full Text] [Related]
17. Predictors of relapse in steroid-sensitive nephrotic syndrome.
Noer MS.
Southeast Asian J Trop Med Public Health; 2005 Sep 23; 36(5):1313-20. PubMed ID: 16438164
[Abstract] [Full Text] [Related]
18. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S.
Nihon Jinzo Gakkai Shi; 2010 Sep 23; 52(8):1029-36. PubMed ID: 21254699
[Abstract] [Full Text] [Related]
19. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
Simmonds J, Grundy N, Trompeter R, Tullus K.
Arch Dis Child; 2010 Feb 23; 95(2):146-9. PubMed ID: 20172895
[Abstract] [Full Text] [Related]
20. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 23; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
